» Articles » PMID: 17983269

The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida Albicans

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2007 Nov 7
PMID 17983269
Citations 172
Authors
Affiliations
Soon will be listed here.
Abstract

Constitutive overexpression of the MDR1 (multidrug resistance) gene, which encodes a multidrug efflux pump of the major facilitator superfamily, is a frequent cause of resistance to fluconazole and other toxic compounds in clinical Candida albicans strains, but the mechanism of MDR1 upregulation has not been resolved. By genome-wide gene expression analysis we have identified a zinc cluster transcription factor, designated as MRR1 (multidrug resistance regulator), that was coordinately upregulated with MDR1 in drug-resistant, clinical C. albicans isolates. Inactivation of MRR1 in two such drug-resistant isolates abolished both MDR1 expression and multidrug resistance. Sequence analysis of the MRR1 alleles of two matched drug-sensitive and drug-resistant C. albicans isolate pairs showed that the resistant isolates had become homozygous for MRR1 alleles that contained single nucleotide substitutions, resulting in a P683S exchange in one isolate and a G997V substitution in the other isolate. Introduction of these mutated alleles into a drug-susceptible C. albicans strain resulted in constitutive MDR1 overexpression and multidrug resistance. By comparing the transcriptional profiles of drug-resistant C. albicans isolates and mrr1Delta mutants derived from them and of C. albicans strains carrying wild-type and mutated MRR1 alleles, we defined the target genes that are controlled by Mrr1p. Many of the Mrr1p target genes encode oxidoreductases, whose upregulation in fluconazole-resistant isolates may help to prevent cell damage resulting from the generation of toxic molecules in the presence of fluconazole and thereby contribute to drug resistance. The identification of MRR1 as the central regulator of the MDR1 efflux pump and the elucidation of the mutations that have occurred in fluconazole-resistant, clinical C. albicans isolates and result in constitutive activity of this trancription factor provide detailed insights into the molecular basis of multidrug resistance in this important human fungal pathogen.

Citing Articles

The role of gene copy number variation in antimicrobial resistance in human fungal pathogens.

Jay A, Jordan D, Gerstein A, Landry C NPJ Antimicrob Resist. 2025; 3():1.

PMID: 39781035 PMC: 11703754. DOI: 10.1038/s44259-024-00072-1.


Adaptation of Candida albicans to specific host environments by gain-of-function mutations in transcription factors.

Morschhauser J PLoS Pathog. 2024; 20(11):e1012643.

PMID: 39495716 PMC: 11534201. DOI: 10.1371/journal.ppat.1012643.


Exploration of novel mechanisms of azole resistance in .

Li J, Brandalise D, Coste A, Sanglard D, Lamoth F Antimicrob Agents Chemother. 2024; 68(12):e0126524.

PMID: 39480072 PMC: 11619343. DOI: 10.1128/aac.01265-24.


Strain variation in glycolytic gene regulation.

Kim M, White A, Mitchell A mSphere. 2024; 9(11):e0057924.

PMID: 39431903 PMC: 11580466. DOI: 10.1128/msphere.00579-24.


Single-cell detection of copy number changes reveals dynamic mechanisms of adaptation to antifungals in Candida albicans.

Zhou X, Hilk A, Solis N, Scott N, Beach A, Soisangwan N Nat Microbiol. 2024; 9(11):2923-2938.

PMID: 39227665 PMC: 11524788. DOI: 10.1038/s41564-024-01795-7.


References
1.
de Micheli M, Bille J, Schueller C, Sanglard D . A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol. 2002; 43(5):1197-214. DOI: 10.1046/j.1365-2958.2002.02814.x. View

2.
Fling M, Kopf J, Tamarkin A, Gorman J, Smith H, Koltin Y . Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet. 1991; 227(2):318-29. DOI: 10.1007/BF00259685. View

3.
Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A . Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother. 2002; 46(10):3113-7. PMC: 128784. DOI: 10.1128/AAC.46.10.3113-3117.2002. View

4.
Staib P, Moran G, Sullivan D, Coleman D, Morschhauser J . Isogenic strain construction and gene targeting in Candida dubliniensis. J Bacteriol. 2001; 183(9):2859-65. PMC: 99503. DOI: 10.1128/JB.183.9.2859-2865.2001. View

5.
Schmitt M, Brown T, Trumpower B . A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 1990; 18(10):3091-2. PMC: 330876. DOI: 10.1093/nar/18.10.3091. View